that the resting vascular tone is elevated, and the contractile response is enhanced in hypertensive persons and animals compared with normotensive controls [7] [8] [9] [10] [11] [12] [13] .
While many studies have demonstrated that several cation channels such as TRPV, Ca 2+ and K + channels on the plasma membrane of vascular smooth muscle cells (VSMCs) play a pivotal role in the modulation of vascular tone of small arteries and arterioles [4] , recent studies also indicated the involvement of several chloride (Cl -) channels in the regulation of vascular tone and arterial blood pressure [2, [14] [15] [16] .
The volume-regulated CLC-3 Cl -channels may play important functional role in the vascular remodeling during hypertension and stroke [17] [18] [19] . Disruption of the Ca 2+ -activated Ano1 Cl -channels caused a decrease in the systemic blood pressure while upregulation of the Ano1 channels was associated with pulmonary arterial hypertension [20, 21] . We recently found important experimental evidence that the CFTR Cl -channels play a pivotal role in the high-fructose and high-salt diet (HFSD)-induced hypertension. Therefore, CLC-3, Ano1, and CFTR Cl -channels may all play crucial functional roles in the regulation of arterial resistance and blood pressure. While up-regulation of Ano1 may cause the primary hypertension, down-regulation of the CFTR Cl -channels may be the underlying mechanism for the HFSD-induced hypertension. These results provide compelling evidence that Cl -channel subproteome in the VSMCs may be novel molecular targets and mechanisms for the treatment of primary or HFSD-induced hypertension.
S2.2 CLC-3 deficiency prevents atherosclerotic lesion development in ApoE -/-mice
Jing TAO, Can-zhao LIU, Jing YANG, Zhi-zhong XIE, Ming-ming MA, Xiang-yu LI , Fei-ya LI, Guan-lei WANG, Jia-guo ZHOU, Yan-hua DU * , Yong-yuan GUAN Radix Puerariae lobatae (Yege or Gegen) and its products have been widely used in China for the treatment of various diseases, especially for the treatment of cardiocerebrovascular related conditions, such as angina pectoris, myocardial ischemia and cerebral infarction. Since puerarin, the major active component in Pueraria lobata (Gegen), has been commercially used as a cardio-tonic drug in clinical practice and therefore has high potential to be co-administered with warfarin. In order to ensure the safe use of warfarin and puerarin in clinical practice, we further conducted the studies to investigate the potential pharmacokinetics and pharmacodynamics interactions between warfarin and puerarin. Intravenously administered puerarin could alter the pharmacokinetics of warfarin significantly, along with a shortened t 1/2 , decreased AUC 0-96 h and increased clearance of warfarin. In the meantime, warfarin could also significantly change the pharmacokinetics behavior of puerarin with a prolonged t 1/2 , increased AUC 0-96h and decreased clearance. Both oral and intravenous administrations of puerarin could significantly induce the activities and expressions of CYP 2B1, CYP 2C6 and CYP 1A1 (P<0.05). In addition, co-administration of puerarin could reduce the PT of rat plasma via enhancing VKOR and inhibiting TM. In summary, our in vivo and ex vivo rat models demonstrated that puerarin could increase warfarin metabolism and offset warfarin anticoagulation via inducing CYPs, VKOR and inhibiting TM in rats. However, the role of TMEM16A in vascular endothelial dysfunction during hypertension is unclear. In this study, we investigated the specific involvement of TMEM16A in regulating endothelial function and blood pressure and the underlying mechanism. Reverse transcription-polymerase chain reaction, Western blotting, co-immunoprecipitation, confocal imaging, patch-clamp recordings, and TMEM16A endothelial-specific transgenic and knockout mice were used. We found that TMEM16A was expressed abundantly and functioned as a Ca 2+ -activated Cl − channel in endothelial cells. Angiotensin II induced endothelial dysfunction with an increase in TMEM16A expression. The knockout of endothelial-specific TMEM16A significantly lowered the blood pressure and ameliorated endothelial dysfunction in angiotensin II-induced hypertension, whereas the over-expression of endothelial-specific TMEM16A resulted in the opposite effects. These results were related to the increased reactive oxygen species production, Nox2-containing NADPH oxidase activation, and Nox2 and p22phox protein expression that were facilitated by TMEM16A on angiotensin II-induced hypertensive challenge. Moreover, TMEM16A directly bound with Nox2 and reduced the degradation of Nox2 through the proteasome-dependent degradation pathway. Therefore, TMEM16A is a positive regulator of endothelial reactive oxygen species generation via Nox2-containing NADPH oxidase, which induces endothelial dysfunction and hypertension. Modification of TMEM16A may be a novel therapeutic strategy for endothelial dysfunction-associated diseases. Pharmaceutical University, Nanjing, China. # These authors contributed equally to this work.
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To whom correspondence should be addressed. E-mail: dugh@imm.ac.cn Here we investigated the effects and the underlying mechanism of Ginkgolide K (1,10-dihydroxy-3,14-didehydroginkgolide, GK) on cardiac ER stress. Cell death, apoptosis, and ER stress-related signalling pathways were measured in cultured neonatal rat cardiomyocytes (NRCMs), treated with the ER stress inducers tunicamycin, hydrogen peroxide, and thapsigargin. Acute myocardial infarction was established using left coronary artery occlusion in mice, and infarct size was measured by triphenyltetrazolium chloride (TTC) staining. Echocardiography was used to assess heart function and transmission electron microscopy for evaluating ER expansion. GK significantly decreased ER stress-induced cell death in both in vitro and in vivo models. In ischemic injured mice, GK treatment reduced infarct size, rescued heart dysfunction and ameliorated ER dilation. Mechanistic studies revealed that the beneficial effects of GK occur through enhancement of inositolrequiring enzyme 1α (IRE1α)/X box-binding protein-1 (XBP1) activity, which in turn leads to increased ER-associated degradation (ERAD)-mediated clearance of misfolded proteins and autophagy. In addition, GK is also able to partially repress the pro-apoptotic action of regulated IRE1-dependent decay (RIDD) and JNK pathway. GK acts through selective activation of the IRE1α/XBP1 pathway to limit ER stress injury. GK is revealed as a promising therapeutic agent to ameliorate ER stress for treating cardiovascular diseases. E-mail: xjtu1001@126.com As an optimal solution for patients with end stage cardiac failure, heart transplantation has been applied in clinic for decades. However, hypothermic preservation of heart is still limited in 4 to 6 h, and calcium overload over time is known to be an important factor resulting in cell death. To provide longer and safer storage for hearts, our previously study showed that luleolin, which has been applied in traditional Chinese medicine treatment for cardiovascular diseases, could inhibit cell death and the L-type calcium currents during hypothermic preservation to provide better protection for cardiomyocytes. In this study, we further investigated the protective role of luleolin in modulating myocytes calcium cycling. Intracellular calcium overload has been implicated in hypothermiainduced dysfunction of cardiac myocytes. Using University of Wisconsin (UW) solution with 7.5, 15, and 30 μmol/L luleolin to preserve fresh isolated myocytes at 4 °C, respectively, we showed that all three doses of luleolin attenuated calcium overload over 6 h preservation. We further observed that luleolin had a suppressive effect on accumulating mitochondria Ca 2+ uniporter (MCU) and calmodulin (CaM) that induced by cold storage. Besides, the activation of protein kinase A (PKA) and deactivation of Ca 2+ -Mg 2+ -ATPase were also suppressed by luleolin. As the important regulatory proteins and enzymes for myocyte calcium circulation, MCU, CaM, PKA and Ca
2+
-Mg 2+ -ATPase were dramatically changed during hypothermic preservation, leading to cytotoxic calcium overload. In this study, we demonstrated that luleolin confer an cardioprotective effect in inhibiting the changes of calcium regulators during cold storage and therefore ameliorate Ca 2+ overload in rat cardiomyocytes. Keywords: cardiomyocytes; luleolin; calcium; hypothermic preservation Acknowledgements: The study was supported by National Natural Science Foundation of China (No 81360029).
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The endogenous signaling gasotransmitter hydrosulfide (H 2 S) can exert cardioprotective effects in acute myocardial ischemic (AMI) injury. However, the mechanisms for these effects are not completely understood. This study investigated whether sodium hydrogen sulfide (NaHS), an H 2 S donor, could attenuate apoptotic injury through glycogen synthase kinase-3β (GSK-3β)/ β-catenin signaling. The current study utilized an in vivo rat model of AMI injury by occluding the left anterior descending coronary artery. NaHS (0.39, 0.78, or 1.56 mg/kg, intraperitoneally), GSK-3β inhibitor SB216763 (0.6 mg/kg, intravenous), or 1% dimethylsulfoxide (2 mL/kg, intravenous) were administered to rats respectively. The result demonstrated that administration of medium-and highdose NaHS and SB could significantly improve rat cardiac function, as evidenced by increased mean arterial pressure, left ventricular developed pressure, contraction and relaxation rates, and decreased left ventricular end diastolic pressure. Besides, administration of NaHS and SB could attenuate myocardial injury as reflected by reduced apoptotic cell death, serum lactate dehydrogenase concentration, and ameliorate myocardial pathological structure changes. Administration of NaHS and SB increased the concentrations of phosphorylated GSK-3β, p-GSK-3β/ t-GSK-3β ratio, and downstream protein β-catenin. Moreover, Western blot and immunohistochemical analysis of apoptotic signaling pathway proteins further demonstrated the cardioprotective potential of NaHS, as reflected by up-regulated Bcl-2 expression, down-regulated Bax expression, and reduced TUNEL positive staining. These findings suggest that hydrosulfide exerts cardioprotective effects against AMI-induced apoptosis via the GSK-3β/β-catenin signaling pathway. SAA exerts an action on PDGF-BB-induced proliferation via cAMP/PKA/ CREB pathway and blunts PDGF-BB-induced human umbilical artery smooth muscle cell (hUASMC) proliferation via p21 induction. SAA also activated CREB, including phosphorylation at Ser133, and induced its nuclear translocation. SAA inhibits VSMCs proliferation through regulating osteopontin (OPN, a kind of ECM), intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) expression. In addition, SAA does not inhibit the proliferation of endothelial cells (ECs) and the synthesis of NO and eNOS protein expression. The anti-restenosis effects of SAA were evaluated using the model of vascular restenosis established by balloon injury of rat carotid arteries. The results showed that SAA prevented arteries against injury-induced neointimal hyperplasia, lumen narrowing, and thrombosis formation. The mechanism of the actions of SAA are related with upregulating p21 expression and activating CREB in the neointima of balloon-injured arteries in vivo. In conclusion, the SAA exerts beneficial effects in the treatment of angioplasty or in-stent restenosis, and may be developed as the instent drug coating or oral dosage after PTCA, for it has high efficiency in inhibiting VSMCs proliferation and migration and arterial thrombosis formation with no interference on re-endothelialization. Keywords: vascular remodeling; salvianolic acid A; cAMP/PKA/CREB; p21
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